Regulatory Approval

With new AI tools for voice, e-commerce, and in-store sales, Dutchie is betting big on automation. But can technology solve the core challenges of a complex market?

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

A landmark CFTC approval for Kalshi and a key Haruko integration have finally unlocked the massive perpetual futures market for US institutions, heralding a new era.

A new, single-shot vaccine for dogs targets two spreading diseases. This innovation aims to make vet visits less stressful and close critical health gaps.

With a critical 2026 deadline looming, only 1% of defense contractors are ready for new cyber rules. One IT provider's flawless audit offers a new path.

A new cybersecurity mandate is cleaving the defense industry in two. Vistra's recent certification highlights a growing chasm between the compliant few and the unprepared many.

Amid new Ebola fears, one biotech's rapid C1 platform promises 15-day biologics, eyeing a $25B market beyond just pandemic response. But can it deliver?

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Gilat's acquisition of a key Comtech division isn't just a purchase; it's a strategic power play to build a $700M defense tech giant for a new era.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

Fortuna's key environmental win in Senegal de-risks its Diamba Sud gold mine, highlighting the nation's push for responsible resource development.

A new study reveals 99% of European firms feel pressure to scale AI in customer experience, but only 38% have governance, risking trust and compliance.

Northern Trust's new Dublin banking license is more than expansion; it's a calculated response to strict new EU regulations and a major win for Ireland.

SKHTU Exchange touts a localized push for a Malaysian crypto license. But as it courts one of Asia's top regulators, a trail of questionable claims casts a shadow.

As Germany's strict new cybersecurity law reshapes its telecom market, Mavenir's early certification gives it a key advantage in the post-Huawei era.

With UK approval for its EURneffy 1 mg nasal spray, ALK is set to disrupt the pediatric anaphylaxis market by offering a game-changing needle-free alternative.

ACI Worldwide's new partnership with EPI's Wero wallet aims to unify a fragmented market. But can this alliance overcome entrenched global giants?

As Angel Yeast marks 40 years, its latest sustainability report reveals a strategic pivot towards biotech and ESG, setting a new industry standard.

A hidden multi-billion dollar industry promises access to justice but is increasingly blamed for "nuclear verdicts" that raise costs for everyone. Is it a leveler or a liability?

Echo IQ partners with Mayo Clinic to test its AI for cardiac risk in cancer patients, a key move for validation in the burgeoning cardio-oncology sector.